Suri Chahat, Pande Babita, Sahu Tarun, Sahithi Lakkakula Suhasini, Verma Henu Kumar
Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
Lung Health and Immunity, Helmholtz Zentrum Munich, IngolstädterLandstraße 1, 85764 Oberschleißheim, 85764 Munich, Germany.
J Clin Med. 2024 Jul 8;13(13):3977. doi: 10.3390/jcm13133977.
In recent years, remarkable strides have been made in the management of gastrointestinal disorders, transforming the landscape of patient care and outcomes. This article explores the latest breakthroughs in the field, encompassing innovative diagnostic techniques, personalized treatment approaches, and novel therapeutic interventions. Additionally, this article emphasizes the use of precision medicine tailored to individual genetic and microbiome profiles, and the application of artificial intelligence in disease prediction and monitoring. This review highlights the dynamic progress in managing conditions such as inflammatory bowel disease, gastroesophageal reflux disease, irritable bowel syndrome, and gastrointestinal cancers. By delving into these advancements, we offer a glimpse into the promising future of gastroenterology, where multidisciplinary collaborations and cutting-edge technologies converge to provide more effective, patient-centric solutions for individuals grappling with gastrointestinal disorders.
近年来,胃肠道疾病的管理取得了显著进展,改变了患者护理和治疗结果的局面。本文探讨了该领域的最新突破,包括创新的诊断技术、个性化治疗方法和新型治疗干预措施。此外,本文强调了根据个体基因和微生物组特征定制的精准医学的应用,以及人工智能在疾病预测和监测中的应用。本综述突出了在炎症性肠病、胃食管反流病、肠易激综合征和胃肠道癌症等疾病管理方面的动态进展。通过深入研究这些进展,我们瞥见了胃肠病学充满希望的未来,在这个未来中,多学科合作和前沿技术相结合,为患有胃肠道疾病的个人提供更有效、以患者为中心的解决方案。